FI934387A0 - 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION - Google Patents

3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION

Info

Publication number
FI934387A0
FI934387A0 FI934387A FI934387A FI934387A0 FI 934387 A0 FI934387 A0 FI 934387A0 FI 934387 A FI934387 A FI 934387A FI 934387 A FI934387 A FI 934387A FI 934387 A0 FI934387 A0 FI 934387A0
Authority
FI
Finland
Prior art keywords
carboxiamide
oxi
indol
substitutes
pharmaceutical composition
Prior art date
Application number
FI934387A
Other languages
Finnish (fi)
Other versions
FI934387A (en
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI934387A0 publication Critical patent/FI934387A0/en
Publication of FI934387A publication Critical patent/FI934387A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
FI934387A 1992-10-07 1993-10-06 3-Substituted 2-oxyindole-1-carboxyamide is a pharmaceutical composition FI934387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07

Publications (2)

Publication Number Publication Date
FI934387A0 true FI934387A0 (en) 1993-10-06
FI934387A FI934387A (en) 1994-04-08

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934387A FI934387A (en) 1992-10-07 1993-10-06 3-Substituted 2-oxyindole-1-carboxyamide is a pharmaceutical composition

Country Status (21)

Country Link
EP (1) EP0662831A1 (en)
JP (1) JP2721042B2 (en)
KR (1) KR950703338A (en)
CN (1) CN1089138A (en)
AU (1) AU676200B2 (en)
BR (1) BR9307182A (en)
CA (1) CA2146448A1 (en)
CZ (1) CZ282702B6 (en)
EG (1) EG20289A (en)
FI (1) FI934387A (en)
HU (1) HUT68533A (en)
IL (1) IL107122A (en)
MX (1) MX9306222A (en)
MY (1) MY109680A (en)
NO (1) NO951350L (en)
NZ (1) NZ256164A (en)
PL (1) PL174170B1 (en)
RU (1) RU2119353C1 (en)
TW (1) TW438798B (en)
WO (1) WO1994007488A1 (en)
ZA (1) ZA937405B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (en) * 1993-08-26 1996-06-16 Pfizer PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED
AU2517095A (en) * 1994-05-19 1995-12-18 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
JPH10506635A (en) * 1995-04-24 1998-06-30 ファイザー・インコーポレーテッド Inhibition of photolysis of 3-substituted-2-oxindole
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
JP5869764B2 (en) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 Capsule filling composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength

Also Published As

Publication number Publication date
KR950703338A (en) 1995-09-20
PL174170B1 (en) 1998-06-30
PL308307A1 (en) 1995-07-24
HUT68533A (en) 1995-04-27
JPH07507809A (en) 1995-08-31
RU2119353C1 (en) 1998-09-27
EP0662831A1 (en) 1995-07-19
NZ256164A (en) 1997-03-24
CZ87895A3 (en) 1995-10-18
MX9306222A (en) 1994-04-29
JP2721042B2 (en) 1998-03-04
ZA937405B (en) 1995-04-06
CZ282702B6 (en) 1997-09-17
IL107122A0 (en) 1993-12-28
NO951350L (en) 1995-06-06
TW438798B (en) 2001-06-07
EG20289A (en) 1998-07-30
AU676200B2 (en) 1997-03-06
WO1994007488A1 (en) 1994-04-14
IL107122A (en) 1998-08-16
HU9302821D0 (en) 1993-12-28
AU4839293A (en) 1994-04-26
CN1089138A (en) 1994-07-13
FI934387A (en) 1994-04-08
MY109680A (en) 1997-04-30
NO951350D0 (en) 1995-04-06
BR9307182A (en) 1999-03-30
CA2146448A1 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
EE03108B1 (en) Pharmaceutical composition
FI981777A0 (en) Pharmaceutical composition
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
FI944832A0 (en) Pharmaceutical composition
BR1100824A (en) Pharmaceutical composition and composition
DE69325158D1 (en) Photocromic composition
FI930882A (en) PHARMACEUTICAL FORM
NO923127L (en) PHARMACEUTICAL COMBINATION FORM
NO931831D0 (en) PHARMACEUTICAL MIXTURES
BR9200058A (en) PHARMACEUTICAL COMPOUND AND COMPOSITION
MX9200622A (en) PHARMACEUTICAL COMPOSITION
ITMI932540A0 (en) PHARMACEUTICAL COMPOSITION
DE4294862T1 (en) Pharmaceutical composition
NO934145D0 (en) Pharmaceutical compounds
FI931251A (en) PHARMACEUTICAL FORM
BR9507768A (en) Pharmaceutical composition
UA26064A1 (en) PHARMACEUTICAL COMPOSITION
LV10579A (en) Pharmaceutical composition
FI934387A0 (en) 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION
DE69217904D1 (en) composition
FI952377A0 (en) Pharmaceutical ibuprofen compositions
IT1272935B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL-CISTEIN
SE9202820D0 (en) PHARMACEUTICAL COMPOSITION
ITMI922581A0 (en) PHARMACEUTICAL COMPOSITION
ITMI922580A1 (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
FD Application lapsed